BioCT and MassBio actively partner on a number of initiatives. BioCT members are welcome to participate. Are you a tenant at an incubator or a...

Accelerator for Biosciences in Connecticut – ABCT – is a competitive entry, 6-month long program designed to provide entrepreneurship education and regional networking to seed-stage ventures...

Featuring: Graham Goodrich - SVP, Brand Marketing, Biohaven Pharmaceuticals John Grosso, Ph.D, Vice President, Chemistry, Manufacturing, & Controls, Arvinas Dawn Hocevar - President & CEO,...

Accelerator for Biosciences in Connecticut – ABCT – is a competitive entry, 6-month long program designed to provide entrepreneurship education and regional networking to seed-stage ventures...

"We can't teach what we don't know and we can't lead where we can't go" - Malcolm X With the backdrop of current events, please...

With $19 trillion, or nearly 85% of the value of the S&P 500 represented by intangible assets, investment in IP has changed the global landscape. ...

With $19 trillion, or nearly 85% of the value of the S&P 500 represented by intangible assets, investment in IP has changed the global landscape. ...

FEATURING: Leading Investigators, Top Biotech Proposals, Accelerated Awards up to $300K, and a Transformative Virtual Experience. See Yale's leading life sciences investigators with this year's top...

FEATURING: Leading Investigators, Top Biotech Proposals, Accelerated Awards up to $300K, and a Transformative Virtual Experience. See Yale’s leading life sciences investigators with this year’s top...

The second in a two-part series highlighting Connecticut's bioscience footprint. Co-organized by BioCT, PhRMA and the Bipartisan Bioscience Caucus, please join us for the second...